Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease

FASEB Journal

Volumn 25, Issue 9, 2011, Pages 2911-2920

  Dong, Yi Fei ^a   Kataoka, Keiichiro ^a   Tokutomi, Yoshiko ^a   Nako, Hisato ^a   Nakamura, Taishi ^a   Toyama, Kensuke ^a   Sueta, Daisuke ^a   Koibuchi, Nobutaka ^a   Yamamoto, Eiichiro ^a   Ogawa, Hisao ^a   Kim Mitsuyama, Shokei ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Amyloid ; Blood brain barrier; Cognitive function; Inflammation; Oxidative stress

Indexed keywords

3 NITROTYROSINE; AMYLOID BETA PROTEIN[1-40]; ENALAPRIL; EXTRACELLULAR SUPEROXIDE DISMUTASE; IMIDAPRIL; INDUCIBLE NITRIC OXIDE SYNTHASE; PERINDOPRIL; SUPEROXIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; CELL ACTIVATION; COGNITIVE DEFECT; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; FOREBRAIN; HIPPOCAMPUS; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL MEMORY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; ENALAPRIL; HIPPOCAMPUS; IMIDAZOLIDINES; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; SUPEROXIDE DISMUTASE;

MUS MUSCULUS;

EID: 80052647359     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-182873     Document Type: Article

References (35)

1. Kehoe, P. G., and Wilcock, G. K. (2007) Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol. 6, 373-378 (Pubitemid 46389616)
2. Phillips, M. I., and De Oliveira, E. M. (2008) Brain renin angiotensin in disease. J. Mol. Med. 86, 715-722
3. Wright, J. W., and Harding, J. W. (2010) The brain RAS and Alzheimer's disease. Exp. Neurol. 223, 326-333
4. Miners, S., Ashby, E., Baig, S., Harrison, R., Tayler, H., Speedy, E., Prince, J. A., Love, S., and Kehoe, P. G. (2009) Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am. J. Transl. Res. 1, 163-177
5. Arregui, A., Perry, E. K., Rossor, M., and Tomlinson, B. E. (1982) Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J. Neurochem. 38, 1490-1492 (Pubitemid 12039305)
6. Khachaturian, A. S., Zandi, P. P., Lyketsos, C. G., Hayden, K. M., Skoog, I., Norton, M. C., Tschanz, J. T., Mayer, L. S., Welsh-Bohmer, K. A., and Breitner, J. C. (2006) Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch. Neurol. 63, 686-692
7. Ohrui, T., Tomita, N., Sato-Nakagawa, T., Matsui, T., Maruyama, M., Niwa, K., Arai, H., and Sasaki, H. (2004) Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63, 1324-1325 (Pubitemid 39350046)
8. Sink, K. M., Leng, X., Williamson, J., Kritchevsky, S. B., Yaffe, K., Kuller, L., Yasar, S., Atkinson, H., Robbins, M., Psaty, B., and Goff, D. C., Jr. (2009) Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch. Intern. Med. 169, 1195-1202
9. Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon, S., and Chalmers, J. (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163, 1069-1075 (Pubitemid 36548935)
10. Oyama, F., Sawamura, N., Kobayashi, K., Morishima-Kawashima, M., Kuramochi, T., Ito, M., Tomita, T., Maruyama, K., Saido, T. C., Iwatsubo, T., Capell, A., Walter, J., Grunberg, J., Ueyama, Y., Haass, C., and Ihara, Y. (1998) Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. J. Neurochem. 71, 313-322 (Pubitemid 28292564)
11. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (Pubitemid 26332733)
12. Richards, J. G., Higgins, G. A., Ouagazzal, A. M., Ozmen, L., Kew, J. N., Bohrmann, B., Malherbe, P., Brockhaus, M., Loetscher, H., Czech, C., Huber, G., Bluethmann, H., Jacobsen, H., and Kemp, J. A. (2003) PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J. Neurosci. 23, 8989-9003 (Pubitemid 37210912)
13. Alkam, T., Nitta, A., Mizoguchi, H., Itoh, A., and Nabeshima, T. (2007) A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ(25-35). Behav. Brain Res. 180, 139-145 (Pubitemid 46719420)
14. Maurice, T., Lockhart, B. P., and Privat, A. (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706, 181-193 (Pubitemid 26048681)
15. Mamiya, T., and Ukai, M. (2001) [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br. J. Pharmacol. 134, 1597-1599 (Pubitemid 34038091)
16. Yamamoto, E., Yamashita, T., Tanaka, T., Kataoka, K., Tokutomi, Y., Lai, Z. F., Dong, Y. F., Matsuba, S., Ogawa, H., and Kim-Mitsuyama, S. (2007) Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler. Thromb. Vasc. Biol. 27, 556-563
17. Shibata, M., Ohtani, R., Ihara, M., and Tomimoto, H. (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35, 2598-2603 (Pubitemid 39458424)
18. Dong, Y. F., Liu, L., Kataoka, K., Nakamura, T., Fukuda, M., Tokutomi, Y., Nako, H., Ogawa, H., and Kim-Mitsuyama, S. (2010) Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia 53, 180-191
19. Kilander, L., Nyman, H., Boberg, M., Hansson, L., and Lithell, H. (1998) Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 31, 780-786 (Pubitemid 28108576)
20. Skoog, I., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L. A., Nilsson, L., Persson, G., Oden, A., and Svanborg, A. (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145 (Pubitemid 126512042)
21. Pohjasvaara, T., Erkinjuntti, T., Vataja, R., and Kaste, M. (1997) Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 28, 785-792 (Pubitemid 27161464)
22. Tatemichi, T. K., Paik, M., Bagiella, E., Desmond, D. W., Stern, Y., Sano, M., Hauser, W. A., and Mayeux, R. (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44, 1885-1891 (Pubitemid 24319216)
23. Querfurth, H. W., and LaFerla, F. M. (2010) Alzheimer's disease. N. Engl. J. Med. 362, 329-344
24. Van Dam, D., and De Deyn, P. P. (2006) Drug discovery in dementia: the role of rodent models. Nat. Rev. Drug Discov. 5, 956-970 (Pubitemid 44660608)
25. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., and Smith, M. A. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767 (Pubitemid 32678256)
26. Wyss-Coray, T., and Mucke, L. (2002) Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35, 419-432 (Pubitemid 34879943)
27. Malinski, T. (2007) Nitric oxide and nitroxidative stress in Alzheimer's disease. J. Alzheimers Dis. 11, 207-218
28. Tran, M. H., Yamada, K., Nakajima, A., Mizuno, M., He, J., Kamei, H., and Nabeshima, T. (2003) Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction. Mol. Psychiatry 8, 407-412 (Pubitemid 36609665)
29. Tran, M. H., Yamada, K., Olariu, A., Mizuno, M., Ren, X. H., and Nabeshima, T. (2001) Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J. 15, 1407-1409
30. Hemming, M. L., and Selkoe, D. J. (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J. Biol. Chem. 280, 37644-37650 (Pubitemid 41642372)
31. Hu, J., Igarashi, A., Kamata, M., and Nakagawa, H. (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem. 276, 47863-47868
32. Oba, R., Igarashi, A., Kamata, M., Nagata, K., Takano, S., and Nakagawa, H. (2005) The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. Eur. J. Neurosci. 21, 733-740 (Pubitemid 40363508)
33. Eckman, E. A., Adams, S. K., Troendle, F. J., Stodola, B. A., Kahn, M. A., Fauq, A. H., Xiao, H. D., Bernstein, K. E., and Eckman, C. B. (2006) Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J. Biol. Chem. 281, 30471-30478 (Pubitemid 44582103)
34. Germano, C., and Kinsella, G. J. (2005) Working memory and learning in early Alzheimer's disease. Neuropsychol. Rev. 15, 1-10 (Pubitemid 40576932)
35. Ohrui, T., Matsui, T., Yamaya, M., Arai, H., Ebihara, S., Maruyama, M., and Sasaki, H. (2004) Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J. Am. Geriatr. Soc. 52, 649-650 (Pubitemid 38480653)